Treatment of Refractory Keratitis After a Boston Type I Keratoprosthesis With Corneal Collagen Cross-Linking.
作者： Siamak Zarei-Ghanavati , Fatemeh Irandoost
DOI: 10.1097/ICO.0000000000000509
关键词:
摘要: PURPOSE To report a patient with refractory keratitis after Boston type I keratoprosthesis treated corneal collagen cross-linking (CXL). METHODS Case report. RESULTS A 29-year-old man history of chemical burn in the left eye underwent implantation. He developed infectious 4 months surgery, which did not respond to topical antibiotics. The CXL shield covering optic. Three weeks CXL, infiltration completely resolved. CONCLUSIONS Corneal might be beneficial treatment patients keratoprosthesis.
sci-hub.se 参考文章(11)
Karim Makdoumi, Jes Mortensen, Omid Sorkhabi, Bo-Eric Malmvall, Sven Crafoord, UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study Graefe's Archive for Clinical and Experimental Ophthalmology. ,vol. 250, pp. 95- 102 ,(2012) , 10.1007/S00417-011-1754-1
Anthony J Aldave, Khairidzan M Kamal, Rosalind C Vo, Fei Yu, None, The Boston Type I Keratoprosthesis : Improving Outcomes and Expanding Indications Ophthalmology. ,vol. 116, pp. 640- 651 ,(2009) , 10.1016/J.OPHTHA.2008.12.058
Anthony J Aldave, Virender S Sangwan, Sayan Basu, Samar K Basak, Anna Hovakimyan, Ofelya Gevorgyan, Soliman Al Kharashi, Mohanna Al Jindan, Radhika Tandon, Jeena Mascarenhas, Boris Malyugin, Ma Dominga B Padilla, Quresh Maskati, Nisheeta Agarwala, Johan Hutauruk, Manoj Sharma, Fei Yu, None, International Results with the Boston Type I Keratoprosthesis Ophthalmology. ,vol. 119, pp. 1530- 1538 ,(2012) , 10.1016/J.OPHTHA.2012.02.015
Michelle J Kim, Fei Yu, Anthony J Aldave, None, Microbial Keratitis after Boston Type I Keratoprosthesis Implantation: Incidence, Organisms, Risk Factors, and Outcomes Ophthalmology. ,vol. 120, pp. 2209- 2216 ,(2013) , 10.1016/J.OPHTHA.2013.05.001
Akira Tsugita, Yoshiko Okada, Kihachiro Uehara, Photosensitized inactivation of ribonucleic acids in the presence of riboflavin. Biochimica et Biophysica Acta. ,vol. 103, pp. 360- 363 ,(1965) , 10.1016/0005-2787(65)90182-6
Suy Anne R. Martins, Juan Castro Combs, Guillermo Noguera, Walter Camacho, Priscila Wittmann, Rhonda Walther, Marisol Cano, James Dick, Ashley Behrens, Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Investigative Ophthalmology & Visual Science. ,vol. 49, pp. 3402- 3408 ,(2008) , 10.1167/IOVS.07-1592
Clara C. Chan, Edward J. Holland, Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea. ,vol. 31, pp. 1128- 1134 ,(2012) , 10.1097/ICO.0B013E318245C02A
Marie-Claude Robert, Claes H. Dohlman, A review of corneal melting after Boston Keratoprosthesis. Seminars in Ophthalmology. ,vol. 29, pp. 349- 357 ,(2014) , 10.3109/08820538.2014.959186
Yasin A. Khan, Renata T. Kashiwabuchi, Suy Anne Martins, Juan M. Castro-Combs, Sachin Kalyani, Philip Stanley, David Flikier, Ashley Behrens, Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. ,vol. 118, pp. 324- 331 ,(2011) , 10.1016/J.OPHTHA.2010.06.041
Dalia G. Said, Mohamed S. Elalfy, Zisis Gatzioufas, Ehab S. El-Zakzouk, Mansour A. Hassan, Mohamed Y. Saif, Ahmed A. Zaki, Harminder S. Dua, Farhad Hafezi, Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting. Ophthalmology. ,vol. 121, pp. 1377- 1382 ,(2014) , 10.1016/J.OPHTHA.2014.01.011